Metabolic Comorbidities in Vitiligo: A Brief Review and Report of New Data from a Single-Center Experience
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic Comorbidities in Vitiligo: A Brief Review and Report of New Data from a Single-Center Experience
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 16, Pages 8820
Publisher
MDPI AG
Online
2021-08-17
DOI
10.3390/ijms22168820
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased risk of subclinical atherosclerosis and metabolic syndrome in patients with vitiligo: a real association or a coincidence?
- (2021) Nastaran Namazi et al. Dermatologic Therapy
- Adiponectin as a novel biomarker of disease severity in alopecia areata
- (2021) Anna Stochmal et al. Scientific Reports
- Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross-sectional study
- (2020) Efsun Tanacan et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
- (2020) David Rosmarin et al. LANCET
- Support for increased cardiovascular risk in non‐segmental vitiligo among Egyptians: A hospital‐based, case‐control study
- (2020) Yousra Azzazi et al. Pigment Cell & Melanoma Research
- Systemic aspects of alopecia areata Comment to the article by Lai and Sinclair
- (2020) L. Rudnicka et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- An update on Vitiligo pathogenesis
- (2020) Julien Seneschal et al. Pigment Cell & Melanoma Research
- IL‐17A is not a treatment target in progressive vitiligo
- (2019) Reinhart Speeckaert et al. Pigment Cell & Melanoma Research
- Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo
- (2019) Meri K. Tulic et al. Nature Communications
- Comorbidities in vitiligo: comprehensive review
- (2018) Aisha M. Dahir et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3
- (2018) Katia Boniface et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
- (2018) Wolf-Henning Boehncke Frontiers in Immunology
- Benefit-risk of tofacitinib in patients with moderate to severe chronic plaque psoriasis: Pooled analysis across 6 clinical trials
- (2018) B.E. Strober et al. BRITISH JOURNAL OF DERMATOLOGY
- Involvement of non melanocytic skin cells in vitiligo
- (2018) Emanuela Bastonini et al. EXPERIMENTAL DERMATOLOGY
- Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis
- (2017) Lluís Puig INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease
- (2017) Jillian M. Richmond et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea
- (2017) Jung Min Bae et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure
- (2017) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Differential expression of CXCL9, CXCL10, and IFN-γin vitiligo andalopecia areatapatients
- (2017) Amal Maouia et al. Pigment Cell & Melanoma Research
- CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study
- (2017) Marwa Abdallah et al. Pigment Cell & Melanoma Research
- Increased Risk of Metabolic Syndrome in Patients with Vitiligo
- (2017) Hatice Ataş et al. Balkan Medical Journal
- Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin
- (2017) Maria Lucia Dell’Anna et al. Scientific Reports
- The role of IL-17 in vitiligo: A review
- (2016) Rasnik K. Singh et al. AUTOIMMUNITY REVIEWS
- Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo
- (2016) X. X. Wang et al. BRITISH JOURNAL OF DERMATOLOGY
- The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: an Updated Meta-Analysis
- (2016) Zheng-sheng Yang et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Understanding autoimmunity of vitiligo and alopecia areata
- (2016) Jillian F. Rork et al. CURRENT OPINION IN PEDIATRICS
- Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses
- (2016) Kristin Stelzner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population
- (2016) Krithika Srikanthan et al. International Journal of Medical Sciences
- Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis
- (2016) Yuki M.F. Andersen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Insulin Resistance is Increased in Patients with Vitiligo
- (2016) A Karadag et al. ACTA DERMATO-VENEREOLOGICA
- Prevalence of the Metabolic Syndrome in the United States, 2003-2012
- (2015) Maria Aguilar et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study
- (2015) E. Bartoloni et al. JOURNAL OF INTERNAL MEDICINE
- Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development
- (2015) Li Zhou et al. Pigment Cell & Melanoma Research
- Vitiligo
- (2015) Mauro Picardo et al. Nature Reviews Disease Primers
- Circulating Autoantibodies and Autoimmune Comorbidities in Vitiligo Patients: A Multicenter Italian Study
- (2014) Vito Ingordo et al. DERMATOLOGY
- Type I interferon signature in the initiation of the immune response in vitiligo
- (2014) Antoine Bertolotti et al. Pigment Cell & Melanoma Research
- Co-existence of Chronic Urticaria and Metabolic Syndrome: Clinical Implications
- (2013) Y Ye et al. ACTA DERMATO-VENEREOLOGICA
- Homocysteine and other cardiovascular risk factors in patients with lichen planus
- (2013) N. Saleh et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- SLE and metabolic syndrome
- (2013) B Parker et al. LUPUS
- Vitiligo: A Possible Model of Degenerative Diseases
- (2013) Barbara Bellei et al. PLoS One
- Psoriasis Severity and the Prevalence of Major Medical Comorbidity
- (2013) Howa Yeung et al. JAMA Dermatology
- Metabolic syndrome in vitiligo
- (2012) Aldona Pietrzak et al. Dermatologic Therapy
- A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the Skin
- (2012) John E. Harris et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference
- (2012) K. Ezzedine et al. Pigment Cell & Melanoma Research
- Patients with vitiligo present fewer cardiovascular risk factors: results from a case-control study
- (2011) M. Rodríguez-Martín et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Lipid levels in patients with lichen planus: a case-control study
- (2011) S. Arias-Santiago et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients
- (2010) Maria Lucia Dell'Anna et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Lichen planus and dyslipidaemia: a case-control study
- (2009) J. Dreiher et al. BRITISH JOURNAL OF DERMATOLOGY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women
- (2008) M Sumarac-Dumanovic et al. INTERNATIONAL JOURNAL OF OBESITY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started